Other Global Peers |
BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB-SB (HKEx), BRIDGEBIO PHARMA INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERON PHARMA (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), JOINN (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), Lonza (SGX), SANA BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), GENSCRIPT BIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), VERACYTE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), SEER INC (NASDAQ), VIELA BIO INC (NASDAQ), ALKERMES PLC (NASDAQ), NANTKWEST INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), ARCUS BIOSCIENCES INC (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), NUVATION BIO INC (NYSE), ALLOVIR INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), KURA ONCOLOGY INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), BLUEBIRD BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), BIOATLA INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), JACOBIO-B (HKEx), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SHATTUCK LABS INC (NASDAQ), OCUGEN INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), JW THERAP-B (HKEx), IMMUNOGEN INC (NASDAQ), REGENXBIO INC (NASDAQ), PRECIGEN INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), SANGAMO THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), UNIQURE N.V. (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), NKARTA INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ALECTOR INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), HAOHAI BIOTEC (HKEx), VOR BIOPHARMA INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), JHBP-B (HKEx), MIMEDX GROUP INC (NASDAQ), PERSONALIS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OMEROS CORP (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), INHIBRX INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), KINTOR PHARMA-B (HKEx), KARYOPHARM THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), HUMANIGEN INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), KADMON HLDGS INC (NASDAQ), CHIMERIX INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), CURIS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VAXART INC (NASDAQ), COMPUGEN (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), ATRECA INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), MAGENTA THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AFFIMED N V (NASDAQ), ARDELYX INC (NASDAQ), AGENUS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), GERON CORP (NASDAQ), IVERIC BIO INC (NASDAQ), XBIOTECH INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SINOMAB BIO-B (HKEx), JOUNCE THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), DPHARMA (Bursa), SUMMIT THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AVROBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ESSEX BIO-TECH (HKEx), PUMA BIOTECHNOLOGY INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), LEE'S PHARM (HKEx), UROGEN PHARMA LTD (NASDAQ), ADICET BIO INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ASCLETIS-B (HKEx), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SESEN BIO INC (NASDAQ), VERASTEM INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), ATHERSYS INC (NASDAQ), ONCORUS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), IMMUNOME INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), CHECKMATE PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), ONCONOVA THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), METACRINE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), INMUNE BIO INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BIOVIE INC (NASDAQ), CHIASMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), EQUILLIUM INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), BIOMX INC (NYSE American), EVOGENE LTD (NASDAQ), CEL-SCI CORP (NYSE American), ORGENESIS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CONTRAFECT CORP (NASDAQ), IBIO INC (NYSE American), ENZO BIOCHEM INC (NYSE), LONGEVERON INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), OTONOMY INC (NASDAQ), ARAVIVE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SYNLOGIC INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SAVARA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), UNI-BIO GROUP (HKEx), COHBAR INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), PULMATRIX INCORPORATED (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), REGENT PACIFIC (HKEx), ACORDA THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), BIOCARDIA INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), CT ENTERPRISE (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ORAGENICS INC (NYSE American), PRECIPIO INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), Suntar Eco-City (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), HISTOGEN INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), INMED PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), GEOVAX LABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HAO WEN HLDGS (HKEx) |